X

pharma

Emerging API and Intermediates Maker Focuses on Scale Post-Listing

Anlon Healthcare Ltd (NSE: AHCL), a relatively recent entrant to the public markets following its 2025 IPO, reported its Q3…

Indoco Remedies Q3 Revenue Slips as Losses Widen Despite Operating Recovery

Indoco Remedies Limited (NSE:INDOCO) closed at ₹235.00 on February 3, 2026, up 10.88% from the previous close of ₹211.94, surging…

Indegene posts 31% revenue jump in Q3, crosses $100 million quarterly milestone

Indegene Ltd (NSE:INDGN), a life sciences services firm reported more than 30% year-on-year revenue growth for the December quarter, crossing…

Piramal Pharma Ltd Q3 FY 2026 Financial Results: Navigating Cyclical Headwinds with Strategic Adjustments

Piramal Pharma Ltd (NSE: PPLPHARMA), a leading global pharmaceutical and life sciences company headquartered in Mumbai, reported its financial results…

Aurobindo Pharma Ltd Q2FY25; 9% rise in Profits

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003…

Laurus Labs Ltd Q4 FY24 Earnings Conference Call Insights

Key highlights from Laurus Labs Ltd (LAURUSLABS) Q4 FY24 Earnings Concall R&D Progress Advanced several pipeline projects across offerings and…

Gland Pharma Ltd Q3FY24; 17% fall in Profits

Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume…

EPL Ltd Q3FY24; 38% rise in Profits

EPL Limited (formerly known as Essel Propack Limited),is the largest specialty packaging global company, manufacturing laminated plastic tubes catering to…

Balaji Amines Ltd Q3FY24; 33% fall in Profits

Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main…

Ajanta Pharma Ltd Q3FY24; 56% rise in Profits

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report…